LIDOCAINE AGUETTANT 10 mg/ml, solution for injection in a pre-filled syringe syringe, 5 ml
Active ingredients: Lidocaine hydrochloride, Lidocaine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 5 mlinfiltration;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LIDOCAINE AGUETTANT 10 mg/mL, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- infiltration;intraveineuse
- Presentation description
- 1 seringue(s) préremplie(s) polypropylène de 5 ml
- Marketing authorisation holder
- AGUETTANT
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 16 Feb 2026
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66057023CIP73030084CIP133400930300848Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE LIDOCAÏNE MONOHYDRATÉsolution | — | SA |
| CHLORHYDRATE DE LIDOCAÏNE ANHYDREsolution | 10,0 mg · 1 mL de solution injectable | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.